(Q26796205)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26294722%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Gerald Hochleitner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26294722%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Michael Wendt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26294722%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Alexandre Teruya

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26294722%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Donat R Spahn

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26294722%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Applied Thrombosis-Hemostasis

1 June 2020

language of work or name

English

0 references

publication date

March 2016

0 references

1 March 2016

3 references

27 November 2019

21 December 2019

12 November 2020

4 references

27 November 2019

21 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26294722%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

12 November 2020

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26294722%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26294722%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

109-114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26294722%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial 3.0 Unported

1 June 2020

copyright license

3 references

27 November 2019

21 December 2019

Fibrinogen concentrate in bleeding patients

12 November 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Fresh frozen plasma: the most commonly prescribed hemostatic agent

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

The role of fibrinogen and haemostatic assessment in postpartum haemorrhage: preparations for a randomised controlled trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Safety of fibrinogen concentrate: analysis of more than 27 years of pharmacovigilance data

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Fibrinogen concentrate for bleeding--a systematic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Coagulation management with factor concentrates in liver transplantation: a single-center experience.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Efficacy and safety of fibrinogen concentrate in trauma patients--a systematic review.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Role of fibrinogen in trauma-induced coagulopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Fibrinogen concentrate--a potential universal hemostatic agent

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

The effect of fibrinogen concentrate on thrombocytopenia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Fibrinogen--marker or mediator of vascular disease?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

The therapeutic use of fibrinogen (fraction I of Cohn) in fibrinogen deficiency diseases and thrombocytopenias

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Forgotten transfusion history: John Leacock of Barbados

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

The history of blood transfusion

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Coagulation history, Oxford 1951-53.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Emotional or evidence-based medicine--is there a moral tragedy in haemostatic therapy?

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

The desperate need for good-quality clinical trials to evaluate the optimal source and dose of fibrinogen in managing bleeding

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Pharmacokinetics and safety of fibrinogen concentrate

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Plasma fibrinogen--a major coronary risk factor

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Fibrinogen promotes early atherosclerotic changes of the carotid artery in young, healthy adults

31 May 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029615601494

History of patient blood management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029615601494

Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029615601494

Fibrinogen concentrate in dilutional coagulopathy: a dose study in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029615601494

The factor in the license: in reference to "use of prothrombin complex concentrates and fibrinogen concentrates in the perioperative setting: a systematic review".

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029615601494

Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029615601494

Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029615601494

Introduction of fibrinogen in the treatment of hemostatic disorders during orthotopic liver transplantation: implications in the use of allogenic blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029615601494

The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029615601494

[A randomized, double blind trial of prophylactic fibrinogen to reduce bleeding in cardiac surgery].

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029615601494

Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029615601494

The effect of fibrinogen concentrate administration on coagulation abnormalities in a rat sepsis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029615601494

A randomized, double blind trial of prophylactic fibrinogen to reduce bleeding in cardiac surgery

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Purification and characterization of recombinant human fibrinogen.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4741261

Dried fraction I for clinical use from smallest plasma pools, sterile without filtration

28 November 2018

1 reference

12 December 2020

[Blood coagulation disorders as an obstetrical complication]

1 reference

12 December 2020

Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency

1 reference

12 December 2020

Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model

1 reference

12 December 2020

Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study

1 reference

12 December 2020

Against: Fibrinogen concentrate for management of bleeding: against indiscriminate use

1 reference

12 December 2020

Supplementation of fibrinogen in acquired bleeding disorders: experience, evidence, guidelines, and licences

1 reference

12 December 2020

Comparable effect of recombinant and plasma-derived human fibrinogen concentrate on ex vivo clot formation after cardiac surgery

1 reference

12 December 2020

Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients

1 reference

12 December 2020

Fibrinogen supplementation in cardiac surgery: where are we now and where are we going?

1 reference

12 December 2020

Identifiers

DOI

10.1177/1076029615601494

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26294722%20AND%20SRC:MED&resulttype=core&format=json

release_lsgkjv6rirg65bgiapit6aahja

1 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lsgkjv6rirg65bgiapit6aahja

24 November 2022

mapped directly with Wikidata item

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26294722%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

PubMed publication ID

26294722

2 references